Hypofractionated radiation therapy in breast cancer: A revolutionary breakthrough or a long way to go? [1]

Journal of Clinical Oncology

Volumn 25, Issue 4, 2007, Pages 458-459

  Munshi, Anusheel ^a   Budrukkar, Ashwini ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; BREAST CANCER; BREAST RECONSTRUCTION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; LETTER; MASTECTOMY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; ADJUVANT THERAPY; BREAST TUMOR; CONTROLLED CLINICAL TRIAL; DISEASE FREE SURVIVAL; FEMALE; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; SEGMENTAL MASTECTOMY; TREATMENT OUTCOME;

BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; RADIATION INJURIES; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 33846974381     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.09.1736     Document Type: Letter

References (12)

1. Kamangar F, Dores GM, Anderson WE: Patterns of cancer incidence, mortality, and prevalance across five continents: Defining priorities to reduce caner disparities in different geographic regions of the world. J Clin Oncol 24:2137-2150, 2006
2. Thames HD, Bentzen SM, Turesson I, et al: Time-dose factors in radiotherapy: A review of the human data. Radiother Oncol 19:219-235, 1990
3. Dinshaw KA, Sarin R, Budrukkar AN, et al: Safety and feasibility of breast conserving therapy in Indian women: Two decades of experience at Tata Memorial Hospital. J Surg Oncol 94:105-113, 2006
4. Whelan T, MacKenzie R, Julian J, et al: Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst 94:1143-1150, 2002
5. Shelley W, Brundage M, Hayter C, et al: A shorter fractionation schedule for post lumpectomy breast cancer patients. Int J Radiat Oncol Biol Phys 47:1219-1228, 2000
6. Yarnold J, Ashton A, Bliss J, et al: Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: Long-term results of a randomised trial. Radiother Oncol 75:9-17, 2005
7. Arriagada R, Mouriesse H, Sarrazin D, et al: Radiotherapy alone in breast cancer, I: Analysis of tumor parameters, tumor dose and local control - The experience of the Gustave-Roussy Institute and the Princess Margaret Hospital ductal carcinoma in situ and limited prognostic value in stage II breast cancer. Int J Radiat Oncol Biol Phys 11:1751-1757, 1985
8. Owen JR, Ashton A, Bliss JM, et al: Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: Long-term results of a randomized trial. Lancet Oncol 7:467-471, 2006
9. Touboul E, Belkacemi Y, Lefranc JP, et al: Early breast cancer: Influence of type of boost (electrons vs iridium-192) on local control and cosmesis after conservative surgery and radiation therapy. Radiother Oncol 34:105-113, 1995
10. Munshi A: Dose and fractionation regimens for breast cancer. Lancet Oncology 17:617, 2006
11. Early Breast Cancer Trialists' Collaborative Group: Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomized trials. Lancet 355:1757-1770, 2000
12. Yarnold J, Bloomeld D, LeVay J: Prospective randomized trial testing 5.7Gy and 6.0Gy fractions of whole breast radiotherapy in women with early breast cancer (FAST) trial. Clin Oncol 16:S30, 2004